EV Biologics Inc (YECO)
0.6221
0.00 (0.00%)
USD |
OTCM |
May 01, 16:00
EV Biologics Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2017 | 1.865 |
| December 31, 2016 | 0.9011 |
| September 30, 2016 | 0.6592 |
| June 30, 2016 | 0.5037 |
| March 31, 2016 | 0.1015 |
| December 31, 2015 | 0.1058 |
| Date | Value |
|---|---|
| September 30, 2015 | 0.1091 |
| June 30, 2015 | 0.1709 |
| March 31, 2015 | 0.1846 |
| December 31, 2014 | 0.1982 |
| September 30, 2014 | 0.2096 |
| June 30, 2014 | 0.2059 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| CEL-SCI Corp | -- |
| AIM ImmunoTech Inc | 0.00 |
| IGC Pharma Inc | 0.0152 |
| NovaBay Pharmaceuticals Inc | 0.3431 |
| Protalix BioTherapeutics Inc | 0.6033 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 31.82M |
| Total Liabilities (Quarterly) | 28.89M |
| Shareholders Equity (Quarterly) | 2.930M |